$20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
Ohio Pen/10332865

NEWTON, Mass. - OhioPen --

• Targeting Approximately $20 Million In Revenue And Profitability Over The Next 12 Months
• Completed Strategic Divestiture Retiring Approximately 7% Of Outstanding Shares
• Revenue Growth Accelerated To 70% During The First Quarter Of 2026
• Reducing Annual Operating Expenses By Approximately $6 Million
• Serving More Than 1,000 Clients Including NASA, HHS, McKesson, DaVita, And The Nation Of Qatar

As healthcare systems around the world continue shifting toward digital-first care delivery, telehealth has evolved from a convenience into a critical component of modern healthcare infrastructure. Hospitals, health networks, government agencies, and enterprise healthcare organizations increasingly require scalable solutions capable of improving patient access, reducing costs, addressing physician shortages, and delivering high-quality care regardless of location.

VSee Health, Inc. (N A S D A Q: VSEE) $VSEE has spent years building a platform designed specifically for this evolving healthcare landscape. Today, the company provides telehealth technology, virtual care infrastructure, remote patient monitoring capabilities, AI-powered healthcare workflows, and enterprise healthcare solutions that serve organizations across more than 50 countries worldwide.

Recent corporate developments suggest VSee may be entering one of the most important periods in its history as management focuses on accelerating revenue growth, streamlining operations, improving profitability, and expanding adoption of its digital healthcare platform.

Strategic Transformation Creates A More Focused Company

One of the most important developments for VSee during 2026 was the strategic separation of VSee Lab, a transaction that fundamentally reshaped the company's operational and financial profile.

The transaction not only allowed management to sharpen its focus on higher-growth telehealth and enterprise healthcare opportunities, but also resulted in the retirement of approximately 2.87 million shares of common stock, representing roughly 7% of the company's outstanding shares.

More on Ohio Pen

• The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
• FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
• Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
• Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
• Black Ribbon Productions Launches With Fearless 2026 Horror Slate

Equally important, liabilities associated with the laboratory business were transferred away from VSee, creating a cleaner balance sheet and allowing management to dedicate resources toward scaling its core healthcare technology platform.

The result is a more focused company with a simplified corporate structure, improved shareholder alignment, and a clearer path toward long-term growth.

Revenue Growth Continues To Accelerate

The benefits of this transformation are already becoming visible in the company's operating results.

Management recently reported that revenue increased approximately 60% to $8 million during 2025, while first-quarter 2026 revenue expanded approximately 70% compared to the prior-year period.

Much of this growth is being driven by large Integrated Delivery Network contracts signed throughout 2025 that continue rolling out across multiple states. As these healthcare systems expand utilization of VSee's platform, management believes additional telehealth services and recurring revenue opportunities can be layered into existing relationships.

Chief Executive Officer Dr. Imo Aisiku recently stated that the company believes achieving approximately $20 million in revenue and profitability over the next twelve months is a realistic objective based on current contract deployments, operating improvements, and growth opportunities within the existing pipeline.

Improving Financial Health Strengthens The Investment Story

While revenue growth has accelerated, one of the most compelling aspects of the VSee story may be the company's improving financial profile.

During 2025, VSee increased cash and cash equivalents from approximately $326,000 to more than $5.2 million while simultaneously reducing operating expenses and strengthening its balance sheet through debt-to-equity conversions.

Following the VSee Lab separation, management expects annual operating expenses to decline by approximately $6 million.

This combination of accelerating revenue growth, lower operating expenses, improved liquidity, and a reduced share count has created what many investors view as the most attractive financial setup in the company's history.

More on Ohio Pen

• Actor Dominic Pace Returns to Television and Film
• AI Models are Stealing from Podcasters. Instant IP® Launches Protect the Podcast to Fight Back
• Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
• Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
• Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home

AI-Powered Telehealth Innovation Drives Competitive Advantage

Beyond financial improvements, VSee continues differentiating itself through technology innovation.

In March, the company unveiled what it describes as the world's first fully autonomous telehealth AI robot designed specifically for hospital environments.

Unlike traditional telepresence solutions, the VSee AI Robot can independently navigate hospital hallways, enter patient rooms, position itself at the bedside, and connect patients with remote physicians without requiring staff assistance.

Combined with VSee's no-code and low-code AI Workflow Engine, hospitals can deploy advanced virtual care capabilities in a fraction of the time typically required for large healthcare technology implementations.

For healthcare systems facing staffing shortages and increasing cost pressures, these capabilities could represent a significant competitive advantage.

Positioned For Continued Expansion

With accelerating revenue growth, significant operating expense reductions, a strengthened balance sheet, retirement of approximately 7% of outstanding shares, expanding enterprise healthcare contracts, and innovative AI-powered telehealth solutions, VSee appears increasingly positioned to capitalize on the continuing digital transformation of healthcare.

As healthcare organizations seek scalable, efficient, and technology-driven care delivery solutions, VSee's growing footprint across hospitals, health systems, government agencies, and enterprise healthcare organizations may provide a foundation for sustained long-term growth.

For investors seeking exposure to the rapidly expanding telehealth sector, VSee Health represents a company that is not only growing, but also becoming leaner, more focused, and increasingly aligned with shareholder interests as it pursues what could become its most significant expansion phase to date.

For more information on $VSEE visit: www.vseehealth.com or https://www.idocvms.com

Media Contact:
Company Name:  VSee Health (N A S D A Q: VSEE)
Contact: Justin Smith
Email: jsmith@idocvms.com
Phone: 626-513-1824
Country: United States

DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website